From: A randomized, placebo-controlled, cross-over trial of ketamine in Rett syndrome
Measure | Fixed Effect: Drug vs Placebo | ||
---|---|---|---|
Frequency Band | Coefficient | (95% CI) | P-value |
Left Frontal Power | |||
 Delta | −0.005 | (−0.11, 0.10) | p = 0.92 |
 Theta | −0.02 | (−0.09, 0.05) | p = 0.59 |
 Alpha | 0.02 | (−0.05, 0.08) | p = 0.62 |
 Beta | 0.14 | (0.06, 0.22) | p = 0.001 |
 Gamma | 0.24 | (0.14, 0.33) | p < 0.001 |
 1/f | 0.006 | (0.002, 0.01) | p = 0.004 |
Right Frontal Power | |||
 Delta | −0.04 | (−0.27, 0.06) | p = 0.55 |
 Theta | −0.10 | (−0.10, 0.06) | p = 0.23 |
 Alpha | −0.04 | (−0.18, 0.10) | p = 0.58 |
 Beta | 0.07 | (−0.09, 0.23) | p = 0.40 |
 Gamma | 0.13 | (−0.05, 0.31) | p = 0.23 |
 1/f | 0.004 | (−0.001, 0.009) | p = 0.09 |
Frontal–Temporal connectivity |  | ||
 Delta | 0.04 | (0.001, 0.08) | p = 0.04 |
 Theta | 0.02 | (−0.03, 0.07) | p = 0.32 |
 Alpha | 0.01 | (−0.03, 0.06) | p = 0.57 |
 Beta | −0.01 | (−0.03, 0.003) | p = 0.10 |
 Gamma | −0.01 | (−0.03, 0.01) | p = 0.28 |
Anterior–Posterior connectivity |  | ||
 Delta | −0.07 | (−0.13, −0.01) | p = 0.03 |
 Theta | −0.06 | (−0.12, 0.001) | p = 0.05 |
 Alpha | 0.02 | (−0.01, 0.05) | p = 0.15 |
 Beta | −0.005 | (−0.02, 0.01) | p = 0.49 |
 Gamma | −0.004 | (−0.02, 0.01) | p = 0.64 |
Left–Right connectivity |  |  | |
 Delta | −0.01 | (−0.05, 0.03) | p = 0.50 |
 Theta | −0.07 | (−0.02, 0.03) | p = 0.34 |
 Alpha | 0.02 | (−0.02, 0.05) | p = 0.24 |
 Beta | −0.01 | (−0.05, 0.03) | p = 0.50 |
 Gamma | −0.02 | (−0.05, 0.02) | p = 0.28 |